SCHEMBL1042919

SCHEMBL1042919

Fc1ccccc1-c1nnc2cccnn12

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DCTPP1 Q9H773 3/20 0.44
EGLN2 Q96KS0 1/20 0.43
HSD11B1 P28845 1/20 0.39
PDE2A O00408 2/20 0.38
PDE10A Q9Y233 2/20 0.38
POLB P06746 1/20 0.38
NOTUM Q6P988 1/20 0.38
GABRA1 P14867 2/20 0.37
GABRG2 P18507 2/20 0.37
GABRB3 P28472 2/20 0.37
GABRA5 P31644 2/20 0.37
GABRA3 P34903 2/20 0.37
GABRA2 P47869 2/20 0.37
NPSR1 Q6W5P4 1/20 0.36
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1159554 0.76 GABRG2 (0.38) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL9691130 0.76 HSD11B1 (0.43) DCTPP1EGLN2HSD11B1PDE2APDE10A
SCHEMBL2750732 0.75 BRD4 (0.54) POLBNPSR1KDM4EALDH1A1
SCHEMBL2804193 0.75 KDM4E (0.54) EGLN2POLBKDM4EALDH1A1
SCHEMBL9690834 0.74 PDE2A (0.46) DCTPP1HSD11B1PDE2APDE10APOLB
SCHEMBL15364544 0.74 SMN1; SMN2 (0.50) DCTPP1HSD11B1PDE2APDE10AGABRA1
SCHEMBL15364917 0.74 DCTPP1 (0.46) DCTPP1EGLN2HSD11B1PDE2APDE10A
SCHEMBL19338489 0.72 MKNK1 (0.38) EGLN2KDM4E
SCHEMBL5801474 0.70 MKNK1 (0.53) KDM4EALDH1A1
SCHEMBL16417549 0.69 SMN1; SMN2 (0.41) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2454259-A1 DEUTERIUM-MODIFIED TRIAZOLO-PYRIDAZINE DERIVATIVES AS GABA-A RECEPTOR MODULATORS Concert Pharmaceuticals Inc. (US) 2012-05-23 EP disclosed
WO-2011005520-A1 DEUTERIUM-MODIFIED TRIAZOLO-PYRIDAZINE DERIVATIVES AS GABA-A RECEPTOR MODULATORS CONCERT PHARMACEUTICALS, INC. (US) 2011-01-13 WO disclosed